|
thyrotropin-releasing hormone receptor activity
|
GO_0004997 |
[Combining with thyrotropin-releasing hormone to initiate a change in cell activity.] |
|
transferrin receptor activity
|
GO_0004998 |
[Combining selectively with transferrin, and delivering transferrin into the cell via endocytosis. Transferrin is a major iron carrier protein in vertebrates.] |
|
vasoactive intestinal polypeptide receptor activity
|
GO_0004999 |
[Combining with vasoactive intestinal polypeptide to initiate a change in cell activity.] |
|
obsolete regulation of histone H4-K16 acetylation
|
GO_2000618 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of histone H4-K16 acetylation.] |
|
obsolete negative regulation of histone H4-K16 acetylation
|
GO_2000619 |
[OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of histone H4-K16 acetylation.] |
|
regulation of thyroid-stimulating hormone secretion
|
GO_2000612 |
[Any process that modulates the frequency, rate or extent of thyroid-stimulating hormone secretion.] |
|
regulation of peptide hormone secretion
|
GO_0090276 |
[Any process that modulates the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.] |
|
negative regulation of thyroid-stimulating hormone secretion
|
GO_2000613 |
[Any process that stops, prevents or reduces the frequency, rate or extent of thyroid-stimulating hormone secretion.] |
|
negative regulation of peptide hormone secretion
|
GO_0090278 |
[Any process that decreases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.] |
|
negative regulation of thyroid hormone generation
|
GO_2000610 |
[Any process that stops, prevents or reduces the frequency, rate or extent of thyroid hormone generation.] |
|
negative regulation of hormone metabolic process
|
GO_0032351 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving any hormone.] |
|
positive regulation of thyroid hormone generation
|
GO_2000611 |
[Any process that activates or increases the frequency, rate or extent of thyroid hormone generation.] |
|
obsolete negative regulation of histone H3-K9 acetylation
|
GO_2000616 |
[OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of histone H3-K9 acetylation.] |
|
obsolete positive regulation of histone H3-K9 acetylation
|
GO_2000617 |
[OBSOLETE. Any process that activates or increases the frequency, rate or extent of histone H3-K9 acetylation.] |
|
positive regulation of thyroid-stimulating hormone secretion
|
GO_2000614 |
[Any process that activates or increases the frequency, rate or extent of thyroid-stimulating hormone secretion.] |
|
positive regulation of peptide hormone secretion
|
GO_0090277 |
[Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.] |
|
obsolete regulation of histone H3-K9 acetylation
|
GO_2000615 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of histone H3-K9 acetylation.] |
|
beta-L-Ara4N-lipid A biosynthetic process
|
GO_1901760 |
[The chemical reactions and pathways resulting in the formation of beta-L-Ara4N-lipid A which occurs as a result of modification of the lipid A moiety of lipopolysaccharide by the addition of the sugar 4-amino-4-deoxy-L-arabinose (L-Ara4N). This strategy is adopted by pathogenic Gram-negative bacteria to evade cationic antimicrobial peptides produced by the innate immune system.] |
|
obsolete oxytetracycline metabolic process
|
GO_1901761 |
[OBSOLETE. The chemical reactions and pathways involving oxytetracycline.] |
|
oxytetracycline catabolic process
|
GO_1901762 |
[The chemical reactions and pathways resulting in the breakdown of oxytetracycline.] |